EVP R&D, Chief Medical Officer
EVP R&D, Chief Medical Officer at Alkermes plc., filing insider transactions between 2025-10-15 and 2026-06-01.
| SEC ↗ |
| 2026-03-02 | ALKS | Sale | 9,000 | $29.72 | $267K | SEC ↗ |
| 2026-02-02 | ALKS | Sale | 4,000 | $33.54 | $134K | SEC ↗ |
| 2026-02-02 | ALKS | Sale | 5,000 | $34.24 | $171K | SEC ↗ |
| 2026-01-08 | ALKS | Sale | 5,000 | $30.00 | $150K | SEC ↗ |
| 2026-01-02 | ALKS | Sale | 4,000 | $28.00 | $112K | SEC ↗ |
| 2025-12-03 | ALKS | Sale | 3,748 | $30.00 | $112K | SEC ↗ |
| 2025-12-01 | ALKS | Sale | 4,000 | $29.30 | $117K | SEC ↗ |
| 2025-11-03 | ALKS | Sale | 9,000 | $30.38 | $273K | SEC ↗ |
| 2025-10-15 | ALKS | Sale | 9,000 | $31.53 | $284K | SEC ↗ |